Literature DB >> 1551689

In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion.

H W Ziegler-Heitbrock1, M Blumenstein, E Käfferlein, D Kieper, I Petersmann, S Endres, W A Flegel, H Northoff, G Riethmüller, J G Haas.   

Abstract

Like blood monocytes, the human monocytic cell line Mono Mac 6 can be stimulated by lipopolysaccharide (LPS) at 1 microgram/ml to produce high levels of cytokines. When Mono Mac 6 cells are stimulated for 4-6 hr at 1 x 10(6)/ml, supernatants contain tumour necrosis factor (TNF) at an average of 60 U/ml and interleukin-6 (IL-6) at an average of 1000 U/ml. IL-1 is not detected in the supernatant, but after three freeze-thaw cycles cell-associated IL-1 can be detected (100 U/ml) and with similar amounts of IL-alpha and -beta. Preculture of Mono Mac 6 cells with LPS at 10 ng/ml for 3 days results in cells refractory to subsequent stimulation by LPS at 1 microgram/ml. In the refractory desensitized cells, production of all three cytokines is down-regulated, with a more than 10-fold reduction in protein production. For all three cytokines, this desensitization appears to be regulated at the transcript level, with a strong reduction in specific mRNA as detected by Northern blot analysis. Furthermore, Mono Mac 6 cells can be stimulated by Staphylococcus aureus (LPS contamination less than 10 pg/ml) to produce cytokines. This type of stimulus is unable to overcome desensitization, in that the secretion of TNF in LPS-precultured Mono Mac 6 cells was 10- to 100-fold lower than in Mono Mac 6 cells without LPS preculture. These data show that desensitization in Mono Mac 6 cells affects all three cytokines tested and that it extends to other activating signals, such as staphylococci.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551689      PMCID: PMC1384704     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages.

Authors:  J M Cavaillon; N Haeffner-Cavaillon
Journal:  Cytokine       Date:  1990-09       Impact factor: 3.861

2.  Interleukin-6 induction by a muramyltripeptide derivative in cancer patients.

Authors:  H Frost; J L Murray; H A Chaudri; J Van Damme
Journal:  J Biol Response Mod       Date:  1990-04

3.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

5.  Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes.

Authors:  J L Lepe-Zuniga; J Klostergaard
Journal:  Lymphokine Res       Date:  1990

6.  Altered interleukin-1 production in patients undergoing hemodialysis.

Authors:  M Blumenstein; B Schmidt; R A Ward; H W Ziegler-Heitbrock; H J Gurland
Journal:  Nephron       Date:  1988       Impact factor: 2.847

7.  Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model.

Authors:  J R Izbicki; C Raedler; A Anke; P Brunner; M Siebeck; E Leinisch; R Lüttiken; G Ruckdeschel; D K Wilker; L Schweiberer
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.

Authors:  M D Wewers; S I Rennard; A J Hance; P B Bitterman; R G Crystal
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells.

Authors:  G D Virca; S Y Kim; K B Glaser; R J Ulevitch
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

10.  Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.

Authors:  W E Scales; S W Chensue; I Otterness; S L Kunkel
Journal:  J Leukoc Biol       Date:  1989-05       Impact factor: 4.962

View more
  21 in total

1.  Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes.

Authors:  H Shimauchi; T Ogawa; K Okuda; Y Kusumoto; H Okada
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Chaperone insufficiency links TLR4 protein signaling to endoplasmic reticulum stress.

Authors:  Andressa Coope; Marciane Milanski; Ana P Arruda; Leticia M Ignacio-Souza; Mário J Saad; Gabriel F Anhê; Licio A Velloso
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

3.  Monocytes of individual human subjects display heterogeneous bacterial uptake and antilisterial activity.

Authors:  G Zerlauth; H E Chehadeh; E Maier; Z Schaff; M M Eibl; J W Mannhalter
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.

Authors:  J M Brand; P Neustock; A Kruse; L Alvarez-Ossorio; A Schnabel; H Kirchner
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

6.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14.

Authors:  B Neumeister; M Faigle; M Sommer; U Zähringer; F Stelter; R Menzel; C Schütt; H Northoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.

Authors:  N Hirohashi; D C Morrison
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.